Table 1. Characteristics of 20 non-small cell lung cancer (NSCLC) patients and ten normal controls; NSCLC_01-10 with a short disease-specific survival (DSS), NSCLC_11-20 with a long DSS and 10 normal controls (Norm_01-10).
| Patient ID | Histology | DSS (months) | Status | Stage | T | N | M | Differentiation | Age | Sex |
| NSCLC_01 | AC | 6.5 | LC Dead | IIa | 2a | 1 | 0 | Moderate | 53 | M |
| NSCLC_02 | AC | 7.0 | LC Dead | IIa | 2a | 1 | 0 | Poor | 73 | M |
| NSCLC_03 | SCC | 7.3 | LC Dead | IIIa | 1b | 2 | 0 | Poor | 62 | M |
| NSCLC_04 | AC | 7.4 | LC Dead | IIa | 1b | 1 | 0 | Moderate | 74 | M |
| NSCLC_05 | AC | 7.6 | LC Dead | IIb | 3 | 0 | 0 | Poor | 54 | M |
| NSCLC_06 | SCC | 8.4 | LC Dead | IIb | 3 | 0 | 0 | Well | 53 | M |
| NSCLC_07 | SCC | 8.4 | LC Dead | IIb | 3 | 0 | 0 | Poor | 74 | M |
| NSCLC_08 | SCC | 9.3 | LC Dead | IIa | 2a | 1 | 0 | Poor | 74 | M |
| NSCLC_09 | SCC | 9.6 | LC Dead | IIb | 3 | 0 | 0 | Poor | 68 | F |
| NSCLC_10 | SCC | 9.9 | LC Dead | IIb | 3 | 0 | 0 | Poor | 70 | F |
| NSCLC_11 | SCC | 147.8 | Alive | IIa | 2a | 1 | 0 | Moderate | 53 | F |
| NSCLC_12 | AC | 74.1 | Alive | IIa | 2b | 0 | 0 | Moderate | 75 | M |
| NSCLC_13 | AC | 60.5 | Alive | Ia | 1b | 0 | 0 | Moderate | 75 | F |
| NSCLC_14 | SCC | 147.8 | Alive | IIa | 2b | 0 | 0 | Moderate | 60 | M |
| NSCLC_15 | SCC | 163.8 | Alive | IIIa | 3 | 1 | 0 | Poor | 68 | M |
| NSCLC_16 | AC | 170.5 | Alive | IIa | 2b | 0 | 0 | Moderate | 47 | M |
| NSCLC_17 | SCC | 158.7 | Non-LC Dead | Ib | 2a | 0 | 0 | Moderate | 69 | M |
| NSCLC_18 | AC | 177.4 | Alive | IIb | 3 | 0 | 0 | Moderate | 64 | M |
| NSCLC_19 | SCC | 184.3 | Non-LC Dead | Ia | 1b | 0 | 0 | Moderate | 61 | M |
| NSCLC_20 | SCC | 162.3 | Alive | Ia | 1b | 0 | 0 | Moderate | 53 | M |
| *NORM_01 | AC | 6.5 | LC Dead | IIa | 2a | 1 | 0 | Moderate | 53 | M |
| *NORM_02 | AC | 7.0 | LC Dead | IIa | 2a | 1 | 0 | Poor | 73 | M |
| *NORM_03 | SCC | 8.4 | LC Dead | IIb | 3 | 0 | 0 | Well | 53 | M |
| *NORM_04 | SCC | 147.8 | Alive | IIa | 2a | 1 | 0 | Moderate | 53 | F |
| *NORM_05 | AC | 74.1 | Alive | IIa | 2b | 0 | 0 | Moderate | 75 | M |
| *NORM_06 | AC | 60.5 | Alive | Ia | 1b | 0 | 0 | Moderate | 75 | F |
| *NORM_07 | SCC | 163.8 | Alive | IIIa | 3 | 1 | 0 | Poor | 68 | M |
| *NORM_08 | AC | 170.5 | Alive | IIa | 2b | 0 | 0 | Moderate | 47 | M |
| *NORM_09 | AC | 177.4 | Alive | IIb | 3 | 0 | 0 | Moderate | 64 | M |
| *NORM_10 | SCC | 184.3 | Non-LC Dead | Ia | 1b | 0 | 0 | Moderate | 61 | M |
Abbreviations: SCC, squamous cell carcinoma; AC, adenocarcinoma; DSS; LC, lung cancer related; T, tumor; N, nodal status; M, metastasis.
*Samples from normal lung tissue sites in ten NSCLC patients (NSCLC_01, NSCLC_02, NSCLC_06, NSCLC_11, NSCLC_12, NSCLC_13, NSCLC_15, NSCLC_16, NSCLC_18 and NSCLC_19) were included in the study (NORM_01 - NORM_10).